Fundraising Fox
🦊/Companies
Sign in

Trellis Bioscience

Redwood City, US · Delaware corporation · 3 known investors

Find your way into Trellis Bioscience

86 people in our graph share verified history with the Trellis Bioscience team — schools, employers, funds. One of them is your warm intro.

Jeffrey Finerunlockedknows Stefan Ryser · together at Cytokinetics (overlapped)
×4knows the team · via Corus
knows the team · via American Cyanamid
×3knows the team · via University of Basel
knows the team · via Entelos
×2knows the team · via Ashland University
Biotech

Founders & leadership

LK
Larry KauvarChief Science Officer
SRStefan Ryser
Stefan RyserinPresident and Chief Executive OfficerStefan Ryser is President and CEO of Trellis Bioscience, a clinical-stage biopharmaceutical company developing monoclonal antibodies to treat drug-resistant infections.
GD
Geoff DilloninChief Business OfficerGeoff Dillon is Chief Business Officer at Trellis Bioscience, where he focuses on business development and partnership strategy.
EW
Elisabeth WhitneyChief Operating Officer
NM
Nora MendeChief Financial Officer

Investors · 3

AMR Action Fundreported · 2 sourcesBostonvia Junjun Gao · led
Easton Capitalreported · 2 sourcesNew York · $10M – $20Mvia John Friedman · quoted
New Science Venturesreported · 2 sourcesGreenwich · $2M – $8M

Funding

SEC filings, press & company announcements

$15.1M disclosed across 2 rounds · 2026

▶$6.1MraisedMay 2026 · 16 investors · Biotechnology
Rule 506(b)
Trellis Bioscience Raises $9M in Series C Fundingfinsmes.com · Jul 2026Trellis Bioscience Raises $9 Million Series C To Advance Calpurbatug For Prosthetic Joint Infectionspulse2.com · Jul 2026
Officers, directors & promoters on the filing
  • Stefan RyserExecutive Officer
  • Geoff DillonExecutive Officer
  • Larry KauvarExecutive Officer
  • Elisabeth WhitneyExecutive Officer
  • Nora MendeExecutive Officer
Amount sold
$6.1M
First sale
Jan 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Trellis Bioscience Raises $9 Million Series C To Advance Calpurbatug For Prosthetic Joint Infectionspulse2.com · Jul 2026Trellis Bioscience Raises $9M in Series C Fundingfinsmes.com · Jul 2026The $9M push to crack prosthetic joint infections - Becker’s Spine Reviewbeckersspine.com · Jul 2026Trellis Bioscience Raises $9 Million Series C To Advance Calpurbatug For Prosthetic Joint Infectionspulse2.com · Jul 2026Trellis Bioscience Raises $9M in Series C Fundingfinsmes.com · Jul 2026Trellis Bioscience secures Series C financing for TRL1068 trialfinance.yahoo.com · Jul 2026Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of Biofilm-Targeting Therapy for Prosthetic Joint Infections | citybizcitybiz.co · Jul 2026Trellis Bioscience Raises $9 Million to Advance Phase 2 Trial of Biofilm-Targeting Therapy for Prosthetic Joint Infections | citybizcitybiz.co · Jul 2026

Frequently asked questions

Who founded Trellis Bioscience?
Trellis Bioscience was founded by Larry Kauvar.
Who are Trellis Bioscience's investors?
Trellis Bioscience's investors include AMR Action Fund, Easton Capital, New Science Ventures.
How much funding has Trellis Bioscience raised?
Trellis Bioscience has disclosed $15.1M raised across 2 rounds.
Where is Trellis Bioscience headquartered?
Trellis Bioscience is headquartered in Redwood City, US.